Webinar | Breaking the $50/g barrier with process intensification
Session 1:
Wednesday, June 24, 2026
8 a.m. PST | 11 a.m. EST | 5 p.m. CET
Session 2:
Thursday, June 25, 2026
10 a.m. CET | 2:30 p.m. IST | 5 p.m. HKT
Biologics manufacturers are facing growing pressure from biosimilars, margin compression, and increasing global demand for accessible therapies. At the same time, complex processes, high capital investment, and operational inefficiencies make it challenging to reduce cost of goods (COGs) while maintaining quality and scalability. Reaching production costs below $50/g is quickly becoming a competitive necessity.
In this webinar, we explore how process intensification can help address these challenges with a practical, data-driven approach. Learn how upstream, downstream, and hybrid intensification strategies combine with digital tools and modern single-use technologies to significantly reduce COGs, facility footprint, and waste. We will break down proven approaches like N-1 perfusion, membrane chromatography, and continuous processing, and highlight how they contribute to more efficient and sustainable manufacturing.
We’ll also cover organizational and operational enablers that support successful adoption, helping you move from concept to implementation with confidence. Join us to gain a clear roadmap for achieving cost-efficient biologics manufacturing below $50/g.
What You Will Learn:
- Understand the drivers enabling biologics manufacturers to reach costs below $50/g.
- Learn how intensification strategies reduce CoGs, footprint, and waste.
- Identify steps to accelerate adoption of intensified and continuous workflows.
